Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor
The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to more than 270 million infections and 5.3 million of deaths worldwide. Several major variants of SARS-CoV-2 have emerged and posed challenges in controlling the pandemic. The recently occurred Omicron variant raised serious concerns abou...
Saved in:
Published in | Biochemical and biophysical research communications Vol. 590; pp. 34 - 41 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
29.01.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to more than 270 million infections and 5.3 million of deaths worldwide. Several major variants of SARS-CoV-2 have emerged and posed challenges in controlling the pandemic. The recently occurred Omicron variant raised serious concerns about reducing the efficacy of vaccines and neutralization antibodies due to its vast mutations. We have modelled the complex structure of the human ACE2 protein and the receptor binding domain (RBD) of Omicron Spike protein (S-protein), and conducted atomistic molecular dynamics simulations to study the binding interactions. The analysis shows that the Omicron RBD binds more strongly to the human ACE2 protein than the original strain. The mutations at the ACE2-RBD interface enhance the tight binding by increasing hydrogen bonding interaction and enlarging buried solvent accessible surface area.
•Structure prediction and refinement of SARS-CoV-2 spike protein RBD-ACE2 complex for Omicron variant.•Molecular dynamics simulations reveal stronger binding interactions between RBD and ACE2 protein in Omicron.•Mutations on Omicron RBD yield more hydrogen bonds, residue contacts and larger buried surface at the ACE2-RBD interface. |
---|---|
AbstractList | The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to more than 270 million infections and 5.3 million of deaths worldwide. Several major variants of SARS-CoV-2 have emerged and posed challenges in controlling the pandemic. The recently occurred Omicron variant raised serious concerns about reducing the efficacy of vaccines and neutralization antibodies due to its vast mutations. We have modelled the complex structure of the human ACE2 protein and the receptor binding domain (RBD) of Omicron Spike protein (S-protein), and conducted atomistic molecular dynamics simulations to study the binding interactions. The analysis shows that the Omicron RBD binds more strongly to the human ACE2 protein than the original strain. The mutations at the ACE2-RBD interface enhance the tight binding by increasing hydrogen bonding interaction and enlarging buried solvent accessible surface area. The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to more than 270 million infections and 5.3 million of deaths worldwide. Several major variants of SARS-CoV-2 have emerged and posed challenges in controlling the pandemic. The recently occurred Omicron variant raised serious concerns about reducing the efficacy of vaccines and neutralization antibodies due to its vast mutations. We have modelled the complex structure of the human ACE2 protein and the receptor binding domain (RBD) of Omicron Spike protein (S-protein), and conducted atomistic molecular dynamics simulations to study the binding interactions. The analysis shows that the Omicron RBD binds more strongly to the human ACE2 protein than the original strain. The mutations at the ACE2-RBD interface enhance the tight binding by increasing hydrogen bonding interaction and enlarging buried solvent accessible surface area. •Structure prediction and refinement of SARS-CoV-2 spike protein RBD-ACE2 complex for Omicron variant.•Molecular dynamics simulations reveal stronger binding interactions between RBD and ACE2 protein in Omicron.•Mutations on Omicron RBD yield more hydrogen bonds, residue contacts and larger buried surface at the ACE2-RBD interface. The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to more than 270 million infections and 5.3 million of deaths worldwide. Several major variants of SARS-CoV-2 have emerged and posed challenges in controlling the pandemic. The recently occurred Omicron variant raised serious concerns about reducing the efficacy of vaccines and neutralization antibodies due to its vast mutations. We have modelled the complex structure of the human ACE2 protein and the receptor binding domain (RBD) of Omicron Spike protein (S-protein), and conducted atomistic molecular dynamics simulations to study the binding interactions. The analysis shows that the Omicron RBD binds more strongly to the human ACE2 protein than the original strain. The mutations at the ACE2-RBD interface enhance the tight binding by increasing hydrogen bonding interaction and enlarging buried solvent accessible surface area.The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to more than 270 million infections and 5.3 million of deaths worldwide. Several major variants of SARS-CoV-2 have emerged and posed challenges in controlling the pandemic. The recently occurred Omicron variant raised serious concerns about reducing the efficacy of vaccines and neutralization antibodies due to its vast mutations. We have modelled the complex structure of the human ACE2 protein and the receptor binding domain (RBD) of Omicron Spike protein (S-protein), and conducted atomistic molecular dynamics simulations to study the binding interactions. The analysis shows that the Omicron RBD binds more strongly to the human ACE2 protein than the original strain. The mutations at the ACE2-RBD interface enhance the tight binding by increasing hydrogen bonding interaction and enlarging buried solvent accessible surface area. |
Author | Lupala, Cecylia S. Liu, Haiguang Chen, Hong Ye, Yongjin Su, Xiao-Dong |
Author_xml | – sequence: 1 givenname: Cecylia S. orcidid: 0000-0002-6987-5230 surname: Lupala fullname: Lupala, Cecylia S. organization: Complex Systems Division, Beijing Computational Science Research Center, Haidian, Beijing, 100193, People's Republic of China – sequence: 2 givenname: Yongjin surname: Ye fullname: Ye, Yongjin organization: Complex Systems Division, Beijing Computational Science Research Center, Haidian, Beijing, 100193, People's Republic of China – sequence: 3 givenname: Hong surname: Chen fullname: Chen, Hong organization: School of Life Sciences, State Key Laboratory of Protein and Plant Gene Research and Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, 100871, People's Republic of China – sequence: 4 givenname: Xiao-Dong surname: Su fullname: Su, Xiao-Dong email: xdsu@pku.edu.cn organization: School of Life Sciences, State Key Laboratory of Protein and Plant Gene Research and Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, 100871, People's Republic of China – sequence: 5 givenname: Haiguang orcidid: 0000-0001-7324-6632 surname: Liu fullname: Liu, Haiguang email: hgliu@csrc.ac.cn organization: Complex Systems Division, Beijing Computational Science Research Center, Haidian, Beijing, 100193, People's Republic of China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34968782$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkdFqFDEUhoNU7Lb6Al5ILr2ZMSeTyWZAhO3aVqFSaFW8i5lMss0ym6xJZsG3N8u2ol4UrwI53_9zON8JOvLBG4ReAqmBAH-zrvs-6poSCjXQmsy7J2gGpCMVBcKO0IwQwivawbdjdJLSmhAAxrtn6LhhHRdzQWfo-6cpq-yCTzh4fHP2HgeLbxc3t9UyfK0ovt44Hctkp6JTPuNo0jRm7DxOufyvTMS984PzK5wDvps2yuPF8pwWUJttDvE5emrVmMyL-_cUfbk4_7z8UF1dX35cLq4q3bYsVwMMTBvWC61tq7htLNOspXZQPVgKnQEiLLNzxrkiotNcCWZsyxiFnjRaN6fo3aF3O_UbM2jjc1Sj3Ea3UfGnDMrJvyfe3clV2EkxJ5Q3tBS8vi-I4cdkUpYbl7QZR-VNmJIsEGcchCD_gULbQUcFFPTVn2v93ufBQAHEAShnTikaK7U7GClbulECkXvZci33suVetgQqi-wSpf9EH9ofDb09hEyRsXMmyqSd8doMrijLcgjusfgviTzC6w |
CitedBy_id | crossref_primary_10_1016_j_microb_2024_100059 crossref_primary_10_1016_j_ijbiomac_2023_125950 crossref_primary_10_1016_j_heliyon_2024_e38085 crossref_primary_10_3390_vaccines10050743 crossref_primary_10_1038_s41598_025_89548_2 crossref_primary_10_1016_j_jiac_2022_07_016 crossref_primary_10_1099_jgv_0_001735 crossref_primary_10_2174_0113816128275739231106055502 crossref_primary_10_1016_j_biopha_2022_112756 crossref_primary_10_1080_0889311X_2024_2363756 crossref_primary_10_1016_j_arabjc_2023_105493 crossref_primary_10_1016_j_ijbiomac_2024_138751 crossref_primary_10_3390_ijms23126587 crossref_primary_10_2139_ssrn_4137687 crossref_primary_10_1016_j_csbj_2022_08_015 crossref_primary_10_3390_v14061177 crossref_primary_10_1016_j_mtbio_2022_100265 crossref_primary_10_3390_diagnostics13050889 crossref_primary_10_1016_j_envres_2022_112816 crossref_primary_10_1038_s42003_024_06951_7 crossref_primary_10_1002_rmv_2373 crossref_primary_10_3389_fimmu_2022_960094 crossref_primary_10_3390_ijms242216069 crossref_primary_10_3390_biom12111607 crossref_primary_10_3390_ijms231911542 crossref_primary_10_1039_D3SD00092C crossref_primary_10_1007_s10989_024_10630_w crossref_primary_10_2217_fvl_2022_0003 crossref_primary_10_1002_jmv_27936 crossref_primary_10_1016_j_isci_2022_104935 crossref_primary_10_3390_physchem5010008 crossref_primary_10_1007_s12519_022_00659_6 crossref_primary_10_3390_ijms232314796 crossref_primary_10_1016_j_jksus_2023_103082 crossref_primary_10_1039_D1CS01170G crossref_primary_10_34133_research_0124 crossref_primary_10_3390_biom12040572 crossref_primary_10_3390_medicina58020226 crossref_primary_10_1080_21645515_2023_2301632 crossref_primary_10_25259_AJBPS_3_2022 crossref_primary_10_1038_s41392_024_01741_3 crossref_primary_10_3390_ijms23147675 crossref_primary_10_3390_v16071150 crossref_primary_10_1039_D2CP00169A crossref_primary_10_1007_s11356_022_22468_0 crossref_primary_10_3390_biomedicines11112914 crossref_primary_10_3390_v15051129 crossref_primary_10_1016_j_jinf_2022_06_001 crossref_primary_10_1063_5_0188053 crossref_primary_10_3390_ijms25126306 crossref_primary_10_1016_j_prp_2022_154280 crossref_primary_10_1016_j_jmgm_2022_108286 crossref_primary_10_1016_j_ijmmb_2022_10_006 crossref_primary_10_1016_j_eti_2022_102667 crossref_primary_10_2174_2666796703666220827100054 crossref_primary_10_1002_jmv_28882 crossref_primary_10_1371_journal_pone_0285722 crossref_primary_10_3390_ijms23041987 crossref_primary_10_1080_07391102_2022_2095305 crossref_primary_10_1186_s11658_022_00352_6 crossref_primary_10_3390_v15061280 crossref_primary_10_1021_acschembio_3c00066 crossref_primary_10_3390_cimb45020112 crossref_primary_10_3389_fmicb_2022_934993 crossref_primary_10_1016_j_jiph_2022_06_004 crossref_primary_10_3389_fpubh_2022_1050034 crossref_primary_10_3389_fsysb_2024_1284668 crossref_primary_10_1016_j_arabjc_2022_103916 crossref_primary_10_1128_jvi_00118_22 crossref_primary_10_1007_s11033_022_07419_9 crossref_primary_10_1007_s11224_022_02022_x crossref_primary_10_3390_biomedicines10112779 crossref_primary_10_3389_fimmu_2024_1341600 crossref_primary_10_1016_j_ijbiomac_2022_12_120 crossref_primary_10_22207_JPAM_17_3_22 crossref_primary_10_1016_j_antiviral_2022_105428 crossref_primary_10_1128_spectrum_01250_22 crossref_primary_10_7759_cureus_26807 crossref_primary_10_2174_1871525721666230406075646 crossref_primary_10_1128_aac_00083_22 crossref_primary_10_3390_v14091861 crossref_primary_10_3389_fphar_2022_955648 crossref_primary_10_1016_S2666_5247_23_00011_3 crossref_primary_10_1016_j_isci_2022_105202 crossref_primary_10_1016_j_heliyon_2024_e27193 crossref_primary_10_31083_j_fbl2702065 crossref_primary_10_3389_fchem_2022_892093 crossref_primary_10_12677_AMB_2022_112006 crossref_primary_10_54097_hset_v8i_1213 crossref_primary_10_1016_j_bpj_2023_09_003 crossref_primary_10_1021_acs_jmedchem_2c01229 crossref_primary_10_21055_0370_1069_2023_4_156_159 crossref_primary_10_1128_spectrum_02143_22 crossref_primary_10_3389_fmed_2022_825245 crossref_primary_10_3390_tropicalmed7110373 crossref_primary_10_1007_s11357_022_00532_4 crossref_primary_10_1016_j_compbiomed_2022_105903 crossref_primary_10_1016_j_jmgm_2023_108540 crossref_primary_10_3390_v15081752 crossref_primary_10_1016_j_antiviral_2024_106006 crossref_primary_10_3390_v15020408 crossref_primary_10_1016_j_azn_2025_02_001 crossref_primary_10_33073_pjm_2022_053 crossref_primary_10_1002_jcc_27025 crossref_primary_10_1007_s00894_023_05509_4 crossref_primary_10_1016_j_vaccine_2023_12_008 crossref_primary_10_1007_s10753_022_01734_w crossref_primary_10_1016_j_ijbiomac_2022_07_254 crossref_primary_10_1088_0256_307X_39_10_108701 crossref_primary_10_1007_s10238_023_01276_x crossref_primary_10_3389_fimmu_2022_834098 crossref_primary_10_1002_cnl2_46 crossref_primary_10_1007_s10930_022_10065_6 crossref_primary_10_1016_j_opresp_2022_100169 crossref_primary_10_3389_fmicb_2024_1358530 crossref_primary_10_1016_j_bbrc_2023_03_057 crossref_primary_10_1002_pro_4447 crossref_primary_10_2217_imt_2022_0064 crossref_primary_10_1002_jmv_27585 crossref_primary_10_1038_s41598_023_34220_w crossref_primary_10_1093_abt_tbac032 crossref_primary_10_3390_app12115546 crossref_primary_10_3390_ijms23084376 crossref_primary_10_1002_bies_202200060 crossref_primary_10_1155_2022_4813199 crossref_primary_10_1016_j_imu_2022_101074 crossref_primary_10_30629_0023_2149_2023_101_6_265_274 crossref_primary_10_1080_07391102_2022_2142296 crossref_primary_10_3390_ijerph20021647 crossref_primary_10_2217_fvl_2022_0152 crossref_primary_10_1002_slct_202201380 crossref_primary_10_1093_bfgp_elac053 crossref_primary_10_1128_jvi_01250_22 crossref_primary_10_3390_v14081769 crossref_primary_10_1002_jmv_27749 crossref_primary_10_1038_s41598_022_26803_w crossref_primary_10_3390_vaccines12040342 crossref_primary_10_1080_07391102_2023_2283158 crossref_primary_10_3389_fimmu_2022_1012526 crossref_primary_10_1186_s12879_023_08341_6 crossref_primary_10_1002_jmv_27633 crossref_primary_10_1021_acsinfecdis_3c00312 crossref_primary_10_3389_fimmu_2023_1162211 crossref_primary_10_1039_D2NJ05136B crossref_primary_10_1371_journal_pone_0266844 crossref_primary_10_3390_v16010060 crossref_primary_10_1016_j_coviro_2023_101349 crossref_primary_10_1016_j_ijbiomac_2024_129785 crossref_primary_10_1128_spectrum_03120_22 crossref_primary_10_3390_antib12010017 crossref_primary_10_5812_jjm_137863 crossref_primary_10_1021_acs_jpclett_2c01155 crossref_primary_10_1021_acs_jpcb_3c01467 crossref_primary_10_3390_ijms25042174 crossref_primary_10_1016_j_cyto_2024_156592 crossref_primary_10_3390_vaccines10091468 crossref_primary_10_1016_j_compbiomed_2022_105758 crossref_primary_10_3390_v14102292 crossref_primary_10_1021_acs_jcim_2c00397 |
Cites_doi | 10.1126/science.abb2762 10.1073/pnas.2008209117 10.1063/1.328693 10.1002/prot.10613 10.1038/s41562-021-01122-8 10.1073/pnas.2010146117 10.1038/s41422-021-00554-1 10.1063/1.464397 10.47799/pimr.0903.01 10.1103/PhysRevA.31.1695 10.1038/s41586-020-2179-y 10.1038/s41586-020-2180-5 10.15302/J-QB-020-0231 10.1038/s41422-021-00555-0 10.1038/s41577-021-00592-1 10.1016/0263-7855(96)00018-5 10.1126/science.abh1766 10.1021/acs.jctc.5b00935 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H 10.1002/pro.3280 10.1038/s41423-020-0458-z 10.1073/pnas.1705628114 10.1016/j.softx.2015.06.001 10.1016/j.cell.2020.03.045 10.1016/S0140-6736(21)02046-8 10.1007/s11427-020-1637-5 10.1063/1.447334 10.1016/S0022-2836(02)00470-9 10.1016/j.jiph.2021.08.011 |
ContentType | Journal Article |
Copyright | 2021 Elsevier Inc. Copyright © 2021 Elsevier Inc. All rights reserved. 2021 Elsevier Inc. All rights reserved. 2021 Elsevier Inc. |
Copyright_xml | – notice: 2021 Elsevier Inc. – notice: Copyright © 2021 Elsevier Inc. All rights reserved. – notice: 2021 Elsevier Inc. All rights reserved. 2021 Elsevier Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
DOI | 10.1016/j.bbrc.2021.12.079 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1090-2104 |
EndPage | 41 |
ExternalDocumentID | PMC8702632 34968782 10_1016_j_bbrc_2021_12_079 S0006291X21017204 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABYKQ ACDAQ ACGFO ACGFS ACNCT ACRLP ADBBV ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 D0L DM4 DOVZS EBS EFBJH EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W K-O KOM L7B LG5 LX2 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RNS ROL RPZ SCC SDF SDG SDP SES SPCBC SSU SSZ T5K TWZ WH7 XPP XSW ZA5 ZMT ~02 ~G- .55 .GJ .HR 1CY 3O- 9M8 AAHBH AAQXK AATTM AAXKI AAYJJ AAYWO AAYXX ABDPE ABEFU ABWVN ABXDB ACKIV ACRPL ACVFH ADCNI ADFGL ADIYS ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRDE AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CAG CITATION COF EJD FEDTE FGOYB G-2 HLW HVGLF HZ~ MVM OHT R2- RIG SBG SEW SSH UQL WUQ X7M Y6R ZGI ZKB ~KM CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM EFKBS |
ID | FETCH-LOGICAL-c554t-d1d4ce4b8ccf5a6f3f4c452fdab1f219e108f4f7466a089c6a84ef54421b03cc3 |
IEDL.DBID | .~1 |
ISSN | 0006-291X 1090-2104 |
IngestDate | Thu Aug 21 14:14:14 EDT 2025 Thu Jul 10 18:08:19 EDT 2025 Fri Jul 11 10:45:16 EDT 2025 Wed Feb 19 02:25:56 EST 2025 Tue Jul 01 01:44:23 EDT 2025 Thu Apr 24 23:07:00 EDT 2025 Fri Feb 23 02:39:32 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | ACE2 SARS-CoV-2 Omicron mutant Molecular dynamics simulation Receptor binding domain |
Language | English |
License | Copyright © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c554t-d1d4ce4b8ccf5a6f3f4c452fdab1f219e108f4f7466a089c6a84ef54421b03cc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-6987-5230 0000-0001-7324-6632 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8702632 |
PMID | 34968782 |
PQID | 2615919281 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8702632 proquest_miscellaneous_2636461880 proquest_miscellaneous_2615919281 pubmed_primary_34968782 crossref_citationtrail_10_1016_j_bbrc_2021_12_079 crossref_primary_10_1016_j_bbrc_2021_12_079 elsevier_sciencedirect_doi_10_1016_j_bbrc_2021_12_079 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-01-29 |
PublicationDateYYYYMMDD | 2022-01-29 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Biochemical and biophysical research communications |
PublicationTitleAlternate | Biochem Biophys Res Commun |
PublicationYear | 2022 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Ishigami, Zatsepin, Hikita, Conrad, Nelson, Coe, Basu, Grant, Seaberg, Sierra, Hunter, Fromme, Fromme, Yeh, Rousseau (bib1) 2017; 114 Hoover (bib19) 1985; 31 Johns Hopkins Coronavirus Resource Center, (n.d). Nosé (bib18) 1984; 81 Cao, Wang, Jian, Xiao, Song, Yisimayi, Huang, Li, Wang, An, Wang, Wang, Niu, Yang, Liang, Sun, Li, Yu, Cui, Liu, Yang, Du, Zhang, Hao, Shao, Jin, Wang, Xiao, Wang, Xie (bib34) 2021 Darden, York, Pedersen (bib22) 1993; 98 Krause, Fleming, Peto, Longini, Figueroa, Sterne, Cravioto, Rees, Higgins, Boutron, Pan, Gruber, Arora, Kazi, Gaspar, Swaminathan, Ryan, Henao-Restrepo (bib5) 2021; 398 Abraham, Murtola, Schulz, Páll, Smith, Hess, Lindah (bib21) 2015; 1–2 Wang, Liu, Gao (bib12) 2020; 117 Jurrus, Engel, Star, Monson, Brandi, Felberg, Brookes, Wilson, Chen, Liles, Chun, Li, Gohara, Dolinsky, Konecny, Koes, Nielsen, Head-Gordon, Geng, Krasny, Wei, Holst, McCammon, Baker (bib25) 2018; 27 Humphrey, Dalke, Schulten (bib24) 1996; 14 Yi, Sun, Ye, Ding, Liu, Yang, Lu, Zhang, Ma, Gu, Qu, Xu, Shi, Ling, Sun (bib29) 2020; 17 Lan, Ge, Yu, Shan, Zhou, Fan, Zhang, Shi, Wang, Zhang, Wang (bib31) 2020 Shang, Ye, Shi, Wan, Luo, Aihara, Geng, Auerbach, Li (bib10) 2020; 581 Mathieu, Ritchie, Ortiz-Ospina, Roser, Hasell, Appel, Giattino, Rodés-Guirao (bib3) 2021; 5 (accessed December 9, 2021).. Damas, Hughes, Keough, Painter, Persky, Corbo, Hiller, Koepfli, Pfenning, Zhao, Genereux, Swofford, Pollard, Ryder, Nweeia, Lindblad-Toh, Teeling, Karlsson, Lewin (bib15) 2020; 117 Vashi, Coiado (bib6) 2021; 14 Wang, Zhou, Zhang, Yang, Schramm, Shi, Pegu, Oloniniyi, Henry, Darko, Narpala, Hatcher, Martinez, Tsybovsky, Phung, Abiona, Antia, Cale, Chang, Choe, Corbett, Davis, DiPiazza, Gordon, Hait, Hermanus, Kgagudi, Laboune, Leung, Liu, Mason, Nazzari, Novik, O'Connell, O'Dell, Olia, Schmidt, Stephens, Stringham, Talana, Teng, Wagner, Widge, Zhang, Roederer, Ledgerwood, Ruckwardt, Gaudinski, Moore, Doria-Rose, Baric, Graham, McDermott, Douek, Kwong, Mascola, Sullivan, Misasi (bib7) 2021; 373 Jacobson, Pincus, Rapp, Day, Honig, Shaw, Friesner (bib27) 2004; 55 Wang, Zhang, Wu, Niu, Song, Zhang, Lu, Qiao, Hu, Yuen, Wang, Zhou, Yan, Qi (bib30) 2020; 181 (accessed December 13, 2021). Yan, Zhang, Li, Xia, Guo, Zhou (bib11) 2020; 367 Tregoning, Flight, Higham, Wang, Pierce (bib4) 2021 Xu, Wang, Zhao, Liang, Peng, Song, Wu, Wang, Su (bib33) 2021; 31 Parrinello, Rahman (bib20) 1981; 52 (accessed December 9, 2021). Schrödinger (bib26) 2021 Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern, (n.d.). Du, Liu, Zhang, Xiao, Yasimayi, Huang, Wang, Cao, Xie, Xiao (bib32) 2021; 31 Science Brief: Omicron (B.1.1.529) Variant | CDC, (n.d.). Lupala, Kumar, Su, Wu, Liu (bib16) 2021 Lee, Cheng, Swails, Yeom, Eastman, Lemkul, Wei, Buckner, Jeong, Qi, Jo, Pande, Case, Brooks, MacKerell, Klauda, Im (bib17) 2016; 12 Lupala, Li, Lei, Chen, Qi, Liu, Su (bib13) 2021; 9 Jacobson, Friesner, Xiang, Honig (bib28) 2002; 320 Hess, Bekker, Berendsen, Fraaije (bib23) 1997; 18 Xu, Chen, Wang, Feng, Zhou, Li, Zhong, Hao (bib14) 2020; 63 Wang (10.1016/j.bbrc.2021.12.079_bib7) 2021; 373 Tregoning (10.1016/j.bbrc.2021.12.079_bib4) 2021 10.1016/j.bbrc.2021.12.079_bib9 Hoover (10.1016/j.bbrc.2021.12.079_bib19) 1985; 31 Lupala (10.1016/j.bbrc.2021.12.079_bib13) 2021; 9 10.1016/j.bbrc.2021.12.079_bib8 Damas (10.1016/j.bbrc.2021.12.079_bib15) 2020; 117 Parrinello (10.1016/j.bbrc.2021.12.079_bib20) 1981; 52 Lan (10.1016/j.bbrc.2021.12.079_bib31) 2020 Vashi (10.1016/j.bbrc.2021.12.079_bib6) 2021; 14 Cao (10.1016/j.bbrc.2021.12.079_bib34) 2021 Xu (10.1016/j.bbrc.2021.12.079_bib14) 2020; 63 Ishigami (10.1016/j.bbrc.2021.12.079_bib1) 2017; 114 Du (10.1016/j.bbrc.2021.12.079_bib32) 2021; 31 Mathieu (10.1016/j.bbrc.2021.12.079_bib3) 2021; 5 Humphrey (10.1016/j.bbrc.2021.12.079_bib24) 1996; 14 Xu (10.1016/j.bbrc.2021.12.079_bib33) 2021; 31 Darden (10.1016/j.bbrc.2021.12.079_bib22) 1993; 98 Jacobson (10.1016/j.bbrc.2021.12.079_bib28) 2002; 320 Lupala (10.1016/j.bbrc.2021.12.079_bib16) 2021 Jacobson (10.1016/j.bbrc.2021.12.079_bib27) 2004; 55 Hess (10.1016/j.bbrc.2021.12.079_bib23) 1997; 18 Yi (10.1016/j.bbrc.2021.12.079_bib29) 2020; 17 10.1016/j.bbrc.2021.12.079_bib2 Lee (10.1016/j.bbrc.2021.12.079_bib17) 2016; 12 Krause (10.1016/j.bbrc.2021.12.079_bib5) 2021; 398 Yan (10.1016/j.bbrc.2021.12.079_bib11) 2020; 367 Wang (10.1016/j.bbrc.2021.12.079_bib30) 2020; 181 Shang (10.1016/j.bbrc.2021.12.079_bib10) 2020; 581 Nosé (10.1016/j.bbrc.2021.12.079_bib18) 1984; 81 Abraham (10.1016/j.bbrc.2021.12.079_bib21) 2015; 1–2 Jurrus (10.1016/j.bbrc.2021.12.079_bib25) 2018; 27 Schrödinger (10.1016/j.bbrc.2021.12.079_bib26) 2021 Wang (10.1016/j.bbrc.2021.12.079_bib12) 2020; 117 |
References_xml | – reference: (accessed December 9, 2021). – year: 2021 ident: bib26 article-title: Schrödinger Release 2021-4: Prime – volume: 52 start-page: 7182 year: 1981 end-page: 7190 ident: bib20 article-title: Polymorphic transitions in single crystals: a new molecular dynamics method publication-title: J. Appl. Phys. – volume: 373 year: 2021 ident: bib7 article-title: Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants publication-title: Science – volume: 9 start-page: 61 year: 2021 ident: bib13 article-title: Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein publication-title: Quant. Biol. – volume: 398 start-page: 1377 year: 2021 end-page: 1380 ident: bib5 article-title: Considerations in boosting COVID-19 vaccine immune responses publication-title: Lancet – year: 2020 ident: bib31 article-title: Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor publication-title: Nature – volume: 367 start-page: 1444 year: 2020 end-page: 1448 ident: bib11 article-title: Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 publication-title: Science – volume: 63 start-page: 457 year: 2020 end-page: 460 ident: bib14 article-title: Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission publication-title: Sci. China Life Sci. – volume: 1–2 start-page: 19 year: 2015 end-page: 25 ident: bib21 article-title: Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers publication-title: SoftwareX – reference: Johns Hopkins Coronavirus Resource Center, (n.d). – volume: 117 start-page: 22311 year: 2020 end-page: 22322 ident: bib15 article-title: Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 18 start-page: 1463 year: 1997 end-page: 1472 ident: bib23 article-title: LINCS: a linear constraint solver for molecular simulations publication-title: J. Comput. Chem. – volume: 55 start-page: 351 year: 2004 end-page: 367 ident: bib27 article-title: A hierarchical approach to all-atom protein loop prediction publication-title: Proteins Struct. Funct. Bioinforma. – volume: 320 start-page: 597 year: 2002 end-page: 608 ident: bib28 article-title: On the role of the crystal environment in determining protein side-chain conformations publication-title: J. Mol. Biol. – volume: 114 start-page: 8011 year: 2017 end-page: 8016 ident: bib1 article-title: Crystal structure of CO-bound cytochrome c oxidase determined by serial femtosecond X-ray crystallography at room temperature publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 27 start-page: 112 year: 2018 end-page: 128 ident: bib25 article-title: Improvements to the APBS biomolecular solvation software suite publication-title: Protein Sci. – volume: 14 start-page: 33 year: 1996 end-page: 38 ident: bib24 article-title: VMD: visual molecular dynamics publication-title: J. Mol. Graph. – volume: 31 start-page: 1130 year: 2021 end-page: 1133 ident: bib32 article-title: Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants publication-title: Cell Res. – reference: Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern, (n.d.). – start-page: 626 year: 2021 end-page: 636 ident: bib4 article-title: Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape publication-title: Nat. Rev. Immunol. – volume: 98 start-page: 10089 year: 1993 end-page: 10092 ident: bib22 article-title: Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems publication-title: J. Chem. Phys. – reference: (accessed December 9, 2021).. – volume: 181 start-page: 894 year: 2020 end-page: 904 ident: bib30 article-title: Structural and functional basis of SARS-CoV-2 entry by using human ACE2 publication-title: Cell – volume: 31 start-page: 1126 year: 2021 end-page: 1129 ident: bib33 article-title: Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants publication-title: Cell Res. – reference: Science Brief: Omicron (B.1.1.529) Variant | CDC, (n.d.). – volume: 117 start-page: 13967 year: 2020 end-page: 13974 ident: bib12 article-title: Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions publication-title: Proc. Natl. Acad. Sci. Unit. States Am. – reference: (accessed December 13, 2021). – volume: 31 start-page: 1695 year: 1985 end-page: 1697 ident: bib19 article-title: Canonical dynamics: equilibrium phase-space distributions publication-title: Phys. Rev. A. – year: 2021 ident: bib34 article-title: B.1.1.529 Escapes the Majority of SARS-CoV-2 Neutralizing Antibodies of Diverse Epitopes – volume: 14 start-page: 1461 year: 2021 end-page: 1465 ident: bib6 article-title: The future of COVID-19: a vaccine review publication-title: J. Infect. Public Health. – volume: 12 start-page: 405 year: 2016 end-page: 413 ident: bib17 article-title: CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field publication-title: J. Chem. Theor. Comput. – year: 2021 ident: bib16 article-title: Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain publication-title: Comput. Biol. Med. – volume: 5 start-page: 947 year: 2021 end-page: 953 ident: bib3 article-title: A global database of COVID-19 vaccinations publication-title: Nat. Hum. Behav. – volume: 581 start-page: 221 year: 2020 end-page: 224 ident: bib10 article-title: Structural basis of receptor recognition by SARS-CoV-2 publication-title: Nature – volume: 81 start-page: 511 year: 1984 end-page: 519 ident: bib18 article-title: A unified formulation of the constant temperature molecular dynamics methods publication-title: J. Chem. Phys. – volume: 17 start-page: 621 year: 2020 end-page: 630 ident: bib29 article-title: Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies publication-title: Cell. Mol. Immunol. – volume: 367 start-page: 1444 year: 2020 ident: 10.1016/j.bbrc.2021.12.079_bib11 article-title: Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 publication-title: Science doi: 10.1126/science.abb2762 – volume: 117 start-page: 13967 year: 2020 ident: 10.1016/j.bbrc.2021.12.079_bib12 article-title: Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions publication-title: Proc. Natl. Acad. Sci. Unit. States Am. doi: 10.1073/pnas.2008209117 – volume: 52 start-page: 7182 year: 1981 ident: 10.1016/j.bbrc.2021.12.079_bib20 article-title: Polymorphic transitions in single crystals: a new molecular dynamics method publication-title: J. Appl. Phys. doi: 10.1063/1.328693 – volume: 55 start-page: 351 year: 2004 ident: 10.1016/j.bbrc.2021.12.079_bib27 article-title: A hierarchical approach to all-atom protein loop prediction publication-title: Proteins Struct. Funct. Bioinforma. doi: 10.1002/prot.10613 – volume: 5 start-page: 947 year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib3 article-title: A global database of COVID-19 vaccinations publication-title: Nat. Hum. Behav. doi: 10.1038/s41562-021-01122-8 – volume: 117 start-page: 22311 year: 2020 ident: 10.1016/j.bbrc.2021.12.079_bib15 article-title: Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.2010146117 – volume: 31 start-page: 1126 year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib33 article-title: Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants publication-title: Cell Res. doi: 10.1038/s41422-021-00554-1 – ident: 10.1016/j.bbrc.2021.12.079_bib2 – volume: 98 start-page: 10089 year: 1993 ident: 10.1016/j.bbrc.2021.12.079_bib22 article-title: Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems publication-title: J. Chem. Phys. doi: 10.1063/1.464397 – ident: 10.1016/j.bbrc.2021.12.079_bib8 doi: 10.47799/pimr.0903.01 – volume: 31 start-page: 1695 year: 1985 ident: 10.1016/j.bbrc.2021.12.079_bib19 article-title: Canonical dynamics: equilibrium phase-space distributions publication-title: Phys. Rev. A. doi: 10.1103/PhysRevA.31.1695 – year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib26 – volume: 581 start-page: 221 year: 2020 ident: 10.1016/j.bbrc.2021.12.079_bib10 article-title: Structural basis of receptor recognition by SARS-CoV-2 publication-title: Nature doi: 10.1038/s41586-020-2179-y – year: 2020 ident: 10.1016/j.bbrc.2021.12.079_bib31 article-title: Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor publication-title: Nature doi: 10.1038/s41586-020-2180-5 – volume: 9 start-page: 61 year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib13 article-title: Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein publication-title: Quant. Biol. doi: 10.15302/J-QB-020-0231 – volume: 31 start-page: 1130 year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib32 article-title: Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants publication-title: Cell Res. doi: 10.1038/s41422-021-00555-0 – start-page: 626 year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib4 article-title: Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-021-00592-1 – volume: 14 start-page: 33 year: 1996 ident: 10.1016/j.bbrc.2021.12.079_bib24 article-title: VMD: visual molecular dynamics publication-title: J. Mol. Graph. doi: 10.1016/0263-7855(96)00018-5 – volume: 373 year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib7 article-title: Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants publication-title: Science doi: 10.1126/science.abh1766 – volume: 12 start-page: 405 year: 2016 ident: 10.1016/j.bbrc.2021.12.079_bib17 article-title: CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field publication-title: J. Chem. Theor. Comput. doi: 10.1021/acs.jctc.5b00935 – volume: 18 start-page: 1463 year: 1997 ident: 10.1016/j.bbrc.2021.12.079_bib23 article-title: LINCS: a linear constraint solver for molecular simulations publication-title: J. Comput. Chem. doi: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H – volume: 27 start-page: 112 year: 2018 ident: 10.1016/j.bbrc.2021.12.079_bib25 article-title: Improvements to the APBS biomolecular solvation software suite publication-title: Protein Sci. doi: 10.1002/pro.3280 – volume: 17 start-page: 621 year: 2020 ident: 10.1016/j.bbrc.2021.12.079_bib29 article-title: Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-020-0458-z – volume: 114 start-page: 8011 year: 2017 ident: 10.1016/j.bbrc.2021.12.079_bib1 article-title: Crystal structure of CO-bound cytochrome c oxidase determined by serial femtosecond X-ray crystallography at room temperature publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.1705628114 – volume: 1–2 start-page: 19 year: 2015 ident: 10.1016/j.bbrc.2021.12.079_bib21 article-title: Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers publication-title: SoftwareX doi: 10.1016/j.softx.2015.06.001 – volume: 181 start-page: 894 year: 2020 ident: 10.1016/j.bbrc.2021.12.079_bib30 article-title: Structural and functional basis of SARS-CoV-2 entry by using human ACE2 publication-title: Cell doi: 10.1016/j.cell.2020.03.045 – volume: 398 start-page: 1377 year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib5 article-title: Considerations in boosting COVID-19 vaccine immune responses publication-title: Lancet doi: 10.1016/S0140-6736(21)02046-8 – volume: 63 start-page: 457 year: 2020 ident: 10.1016/j.bbrc.2021.12.079_bib14 article-title: Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission publication-title: Sci. China Life Sci. doi: 10.1007/s11427-020-1637-5 – volume: 81 start-page: 511 year: 1984 ident: 10.1016/j.bbrc.2021.12.079_bib18 article-title: A unified formulation of the constant temperature molecular dynamics methods publication-title: J. Chem. Phys. doi: 10.1063/1.447334 – volume: 320 start-page: 597 year: 2002 ident: 10.1016/j.bbrc.2021.12.079_bib28 article-title: On the role of the crystal environment in determining protein side-chain conformations publication-title: J. Mol. Biol. doi: 10.1016/S0022-2836(02)00470-9 – volume: 14 start-page: 1461 year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib6 article-title: The future of COVID-19: a vaccine review publication-title: J. Infect. Public Health. doi: 10.1016/j.jiph.2021.08.011 – year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib34 – year: 2021 ident: 10.1016/j.bbrc.2021.12.079_bib16 article-title: Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain publication-title: Comput. Biol. Med. – ident: 10.1016/j.bbrc.2021.12.079_bib9 |
SSID | ssj0011469 |
Score | 2.6694374 |
Snippet | The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to more than 270 million infections and 5.3 million of deaths worldwide. Several major variants of... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 34 |
SubjectTerms | ACE2 Angiotensin-Converting Enzyme 2 - chemistry Angiotensin-Converting Enzyme 2 - metabolism Binding Sites COVID-19 - metabolism COVID-19 infection Host-Pathogen Interactions Humans hydrogen Molecular Docking Simulation molecular dynamics Molecular Dynamics Simulation Mutation neutralization Omicron mutant pandemic Protein Binding Protein Conformation Protein Interaction Domains and Motifs Receptor binding domain SARS-CoV-2 SARS-CoV-2 - chemistry SARS-CoV-2 - genetics SARS-CoV-2 - physiology Severe acute respiratory syndrome coronavirus 2 solvents Spike Glycoprotein, Coronavirus - chemistry Spike Glycoprotein, Coronavirus - genetics Spike Glycoprotein, Coronavirus - metabolism surface area viruses |
Title | Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor |
URI | https://dx.doi.org/10.1016/j.bbrc.2021.12.079 https://www.ncbi.nlm.nih.gov/pubmed/34968782 https://www.proquest.com/docview/2615919281 https://www.proquest.com/docview/2636461880 https://pubmed.ncbi.nlm.nih.gov/PMC8702632 |
Volume | 590 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqVgguqLRAl4_KSIgLCo0dx-s9pqHVAqJILUV7M7ZjQ1DrVLtZJC78djxOsmIB7YFblIwlxzMez9hvnhF6XoUgvmKZTrQLLpAp7RKhiA1ZitaZUExRHVG-Z3x6yd7O8tkWKodaGIBV9r6_8-nRW_dvjvrRPLqpa6jxTTmdkBkFq6KRE5SxMVj5q58rmAcU3fYhME9Aui-c6TBeWs-BxpCSuCUIcK5_L05_B59_Yih_W5ROd9HdPprERdfhe2jL-j20X_iQSV__wC9wxHfGjfM9dOt4eLpdDre87aPP75fdYfwCNx6fH7_GjcMXxflFUjafEoo_XANiz-PvIacOSsAhO19etbj2eAGb6F_sHOs6VsbgtsHxxj9clCc0CAJgppnfR5enJx_LadLfupCYEFq0SUUqZizTwhiXK-4yxwzLqauUJi74N0tS4ZgbM85VKiaGK8GsyxmjRKeZMdkDtO0bbw8QJqIy2uqUm1Qzp_RE5EIZZzKixkqxdITIMNzS9JTkcDPGlRywZ98kqEiCiiShMqhohF6u2tx0hBwbpfNBi3LNrGRYMTa2ezaoXAaFwCGK8rZZLmTIOPNJCIsF2SSTccaB6W6EHnZmsuorEPSLEJaN0HjNgFYCwPe9_sXXXyPvd3CtwK7_6D__6TG6Q6F2IyVhIjxB2-18aZ-GiKrVh3HKHKKd4s276dkvgbshVA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemTmi8INiAlU8jIV5QtNhxUvcxC5s6thVpH6hvxnZsCNqSqU2R-O-5y0dFAfWBtyixJcd3Pt_Zv_sdIW9zcOJzEZnAeDCBQhsfSM0cRCnGRFILzU2D8p0mk2vxcRbPtkjW58IgrLKz_a1Nb6x19-agm82Du6LAHN8w4WM246hVHDlBt5GdKh6Q7fTkdDJdXSaAMei84CTADl3uTAvzMmaOTIacNaeCiOj69_70t__5J4zyt33p-CF50DmUNG3H_IhsuXKX7KUlBNO3P-k72kA8m7PzXXLvsH_ayfpCb3vky_myvY9f0KqkF4cfaOXpZXpxGWTV54DTT7cI2ivpDwirQQ4UAvTlTU2Lki7wHP2rm1NTNMkxtK5oU_SPptkRh4aImanmj8n18dFVNgm6wguBBe-iDnKWC-uEkdb6WCc-8sKKmPtcG-bBxDkWSi_8SCSJDuXYJloK52MhODNhZG30hAzKqnT7hDKZW-NMmNjQCK_NWMZSW28jpkdai3BIWD_dynas5Fgc40b18LPvCkWkUESKcQUiGpL3qz53LSfHxtZxL0W1plkKNo2N_d70IlcgELxH0aWrlgsFQWc8Bs9Ysk1tokQkSHY3JE9bNVmNFTn6JXhmQzJaU6BVA6T8Xv9SFt8a6m-wrkiw_-w__-k12ZlcnZ-ps5Pp6XNyn2MqR8hgUbwgg3q-dC_BwarNq24B_QJV2SQF |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mutations+on+RBD+of+SARS-CoV-2+Omicron+variant+result+in+stronger+binding+to+human+ACE2+receptor&rft.jtitle=Biochemical+and+biophysical+research+communications&rft.au=Lupala%2C+Cecylia+S&rft.au=Ye%2C+Yongjin&rft.au=Chen%2C+Hong&rft.au=Su%2C+Xiao-Dong&rft.date=2022-01-29&rft.eissn=1090-2104&rft.volume=590&rft.spage=34&rft_id=info:doi/10.1016%2Fj.bbrc.2021.12.079&rft_id=info%3Apmid%2F34968782&rft.externalDocID=34968782 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-291X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-291X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-291X&client=summon |